The prognostic value of tumor markers in patients with glioblastoma multiforme: Analysis of 32 patients and review of the literature

J. F. Reavey-Cantwell, R. I. Haroun, M. Zahurak, R. E. Clatterbuck, R. J. Parker, R. Mehta, J. P. Fruehauf, Henry Brem

Research output: Contribution to journalArticle

Abstract

Although several studies have examined brain tumor markers for prognostic value, few investigations have stratified analysis based on specific histologic grade. The objective of this study was to evaluate a single histologic grade of glioma, the grade IV glioma or glioblastoma (World Health Organization Classification), with a comprehensive panel of tumor markers in an attempt to identify those with prognostic significance. Tumor samples from a cohort of patients with glioblastoma multiforme (n = 32) were examined for tumor markers, DNA analysis, and clinical variables in an attempt to determine a 'profile' for this tumor. We used univariate and multivariate statistical analysis to determine the prognostic value of tumor cell ploidy, percent S-phase, DNA index, p53, and Ki-67 labeling index, as well as the variables of gender, race, age, location of tumor, history of chemotherapy, and primary versus recurrent tumor. Two additional tumor markers, multidrug resistance gene 1 and glutathione-S-transferase subtype pi, were included in the sample testing, but were not analyzed statistically. Univariate analysis indicated that increasing age had a strong association with decreased survival. Female gender, increasing Ki-67, no chemotherapy before sample collection, and primary glioblastoma showed some association with decreased survival in the univariate model. The univariate results indicated that race, side of tumor, ploidy, S-phase, DNA index, and p53 had no prognostic value. Multivariate modeling demonstrated that age, gender, and Ki-67 were the strongest factors associated with survival. The relevant literature is reviewed.

Original languageEnglish (US)
Pages (from-to)195-204
Number of pages10
JournalJournal of Neuro-Oncology
Volume55
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Glioblastoma
Tumor Biomarkers
Neoplasms
Ploidies
S Phase
Glioma
Survival
DNA
Glutathione S-Transferase pi
MDR Genes
Drug Therapy
Brain Neoplasms
Multivariate Analysis

Keywords

  • DNA index
  • Glioblastoma multiforme
  • Glutathione-S-transferase pi
  • Ki-67
  • Multidrug resistance gene 1
  • p53
  • Ploidy
  • S-phase fraction

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

The prognostic value of tumor markers in patients with glioblastoma multiforme : Analysis of 32 patients and review of the literature. / Reavey-Cantwell, J. F.; Haroun, R. I.; Zahurak, M.; Clatterbuck, R. E.; Parker, R. J.; Mehta, R.; Fruehauf, J. P.; Brem, Henry.

In: Journal of Neuro-Oncology, Vol. 55, No. 3, 2001, p. 195-204.

Research output: Contribution to journalArticle

Reavey-Cantwell, JF, Haroun, RI, Zahurak, M, Clatterbuck, RE, Parker, RJ, Mehta, R, Fruehauf, JP & Brem, H 2001, 'The prognostic value of tumor markers in patients with glioblastoma multiforme: Analysis of 32 patients and review of the literature', Journal of Neuro-Oncology, vol. 55, no. 3, pp. 195-204. https://doi.org/10.1023/A:1013845004294
Reavey-Cantwell, J. F. ; Haroun, R. I. ; Zahurak, M. ; Clatterbuck, R. E. ; Parker, R. J. ; Mehta, R. ; Fruehauf, J. P. ; Brem, Henry. / The prognostic value of tumor markers in patients with glioblastoma multiforme : Analysis of 32 patients and review of the literature. In: Journal of Neuro-Oncology. 2001 ; Vol. 55, No. 3. pp. 195-204.
@article{d0f1ca7975534006947e8b28fcdcdfa5,
title = "The prognostic value of tumor markers in patients with glioblastoma multiforme: Analysis of 32 patients and review of the literature",
abstract = "Although several studies have examined brain tumor markers for prognostic value, few investigations have stratified analysis based on specific histologic grade. The objective of this study was to evaluate a single histologic grade of glioma, the grade IV glioma or glioblastoma (World Health Organization Classification), with a comprehensive panel of tumor markers in an attempt to identify those with prognostic significance. Tumor samples from a cohort of patients with glioblastoma multiforme (n = 32) were examined for tumor markers, DNA analysis, and clinical variables in an attempt to determine a 'profile' for this tumor. We used univariate and multivariate statistical analysis to determine the prognostic value of tumor cell ploidy, percent S-phase, DNA index, p53, and Ki-67 labeling index, as well as the variables of gender, race, age, location of tumor, history of chemotherapy, and primary versus recurrent tumor. Two additional tumor markers, multidrug resistance gene 1 and glutathione-S-transferase subtype pi, were included in the sample testing, but were not analyzed statistically. Univariate analysis indicated that increasing age had a strong association with decreased survival. Female gender, increasing Ki-67, no chemotherapy before sample collection, and primary glioblastoma showed some association with decreased survival in the univariate model. The univariate results indicated that race, side of tumor, ploidy, S-phase, DNA index, and p53 had no prognostic value. Multivariate modeling demonstrated that age, gender, and Ki-67 were the strongest factors associated with survival. The relevant literature is reviewed.",
keywords = "DNA index, Glioblastoma multiforme, Glutathione-S-transferase pi, Ki-67, Multidrug resistance gene 1, p53, Ploidy, S-phase fraction",
author = "Reavey-Cantwell, {J. F.} and Haroun, {R. I.} and M. Zahurak and Clatterbuck, {R. E.} and Parker, {R. J.} and R. Mehta and Fruehauf, {J. P.} and Henry Brem",
year = "2001",
doi = "10.1023/A:1013845004294",
language = "English (US)",
volume = "55",
pages = "195--204",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - The prognostic value of tumor markers in patients with glioblastoma multiforme

T2 - Analysis of 32 patients and review of the literature

AU - Reavey-Cantwell, J. F.

AU - Haroun, R. I.

AU - Zahurak, M.

AU - Clatterbuck, R. E.

AU - Parker, R. J.

AU - Mehta, R.

AU - Fruehauf, J. P.

AU - Brem, Henry

PY - 2001

Y1 - 2001

N2 - Although several studies have examined brain tumor markers for prognostic value, few investigations have stratified analysis based on specific histologic grade. The objective of this study was to evaluate a single histologic grade of glioma, the grade IV glioma or glioblastoma (World Health Organization Classification), with a comprehensive panel of tumor markers in an attempt to identify those with prognostic significance. Tumor samples from a cohort of patients with glioblastoma multiforme (n = 32) were examined for tumor markers, DNA analysis, and clinical variables in an attempt to determine a 'profile' for this tumor. We used univariate and multivariate statistical analysis to determine the prognostic value of tumor cell ploidy, percent S-phase, DNA index, p53, and Ki-67 labeling index, as well as the variables of gender, race, age, location of tumor, history of chemotherapy, and primary versus recurrent tumor. Two additional tumor markers, multidrug resistance gene 1 and glutathione-S-transferase subtype pi, were included in the sample testing, but were not analyzed statistically. Univariate analysis indicated that increasing age had a strong association with decreased survival. Female gender, increasing Ki-67, no chemotherapy before sample collection, and primary glioblastoma showed some association with decreased survival in the univariate model. The univariate results indicated that race, side of tumor, ploidy, S-phase, DNA index, and p53 had no prognostic value. Multivariate modeling demonstrated that age, gender, and Ki-67 were the strongest factors associated with survival. The relevant literature is reviewed.

AB - Although several studies have examined brain tumor markers for prognostic value, few investigations have stratified analysis based on specific histologic grade. The objective of this study was to evaluate a single histologic grade of glioma, the grade IV glioma or glioblastoma (World Health Organization Classification), with a comprehensive panel of tumor markers in an attempt to identify those with prognostic significance. Tumor samples from a cohort of patients with glioblastoma multiforme (n = 32) were examined for tumor markers, DNA analysis, and clinical variables in an attempt to determine a 'profile' for this tumor. We used univariate and multivariate statistical analysis to determine the prognostic value of tumor cell ploidy, percent S-phase, DNA index, p53, and Ki-67 labeling index, as well as the variables of gender, race, age, location of tumor, history of chemotherapy, and primary versus recurrent tumor. Two additional tumor markers, multidrug resistance gene 1 and glutathione-S-transferase subtype pi, were included in the sample testing, but were not analyzed statistically. Univariate analysis indicated that increasing age had a strong association with decreased survival. Female gender, increasing Ki-67, no chemotherapy before sample collection, and primary glioblastoma showed some association with decreased survival in the univariate model. The univariate results indicated that race, side of tumor, ploidy, S-phase, DNA index, and p53 had no prognostic value. Multivariate modeling demonstrated that age, gender, and Ki-67 were the strongest factors associated with survival. The relevant literature is reviewed.

KW - DNA index

KW - Glioblastoma multiforme

KW - Glutathione-S-transferase pi

KW - Ki-67

KW - Multidrug resistance gene 1

KW - p53

KW - Ploidy

KW - S-phase fraction

UR - http://www.scopus.com/inward/record.url?scp=0035712570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035712570&partnerID=8YFLogxK

U2 - 10.1023/A:1013845004294

DO - 10.1023/A:1013845004294

M3 - Article

C2 - 11859975

AN - SCOPUS:0035712570

VL - 55

SP - 195

EP - 204

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -